| 000 | 01705 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516203700.0 | ||
| 264 | 0 | _c20150921 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1941-2703 | ||
| 024 | 7 |
_a10.1089/jamp.2013.1045 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHibbitts, A | |
| 245 | 0 | 0 |
_aEarly-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells. _h[electronic resource] |
| 260 |
_bJournal of aerosol medicine and pulmonary drug delivery _cDec 2014 |
||
| 300 |
_a466-77 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGenes, Reporter |
| 650 | 0 | 4 | _aHigh-Throughput Screening Assays |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLuciferases _xgenetics |
| 650 | 0 | 4 | _aNanoparticles |
| 650 | 0 | 4 | _aNebulizers and Vaporizers |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTransfection _xmethods |
| 650 | 0 | 4 |
_abeta-Cyclodextrins _xadministration & dosage |
| 700 | 1 | _aO'Mahony, A M | |
| 700 | 1 | _aForde, E | |
| 700 | 1 | _aNolan, L | |
| 700 | 1 | _aOgier, J | |
| 700 | 1 | _aDesgranges, S | |
| 700 | 1 | _aDarcy, R | |
| 700 | 1 | _aMacLoughlin, R | |
| 700 | 1 | _aO'Driscoll, C M | |
| 700 | 1 | _aCryan, S A | |
| 773 | 0 |
_tJournal of aerosol medicine and pulmonary drug delivery _gvol. 27 _gno. 6 _gp. 466-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/jamp.2013.1045 _zAvailable from publisher's website |
| 999 |
_c23673826 _d23673826 |
||